27:I[56264,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js","/_next/static/chunks/2tie5rqwdsi89.js","/_next/static/chunks/2dnipz2c0692b.js","/_next/static/chunks/1mf5iq195c2sn.js","/_next/static/chunks/03wn0-bzh3abk.js","/_next/static/chunks/0_02m0ghanddv.js"],"GuestHistoryRecorder"] 28:I[3004,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js","/_next/static/chunks/2tie5rqwdsi89.js","/_next/static/chunks/2dnipz2c0692b.js","/_next/static/chunks/1mf5iq195c2sn.js","/_next/static/chunks/03wn0-bzh3abk.js","/_next/static/chunks/0_02m0ghanddv.js"],"EmailPreview"] 2b:I[27201,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js"],"IconMark"] 29:Te751,

PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW

RESTORE VOLUME. SUPPORT FIRMNESS. REDEFINE CONTOURS. FIRM. SHOP NOW

Targeted Protocols. Precise Outcomes. Skincare meets Injectables

saypha® is a registered trademark of Croma-Pharma GmbH used under license.

All other products/brand names, whether designated by notice or not (©/™), are trademarks of Obagi Cosmeceuticals LLC, and/or its affiliates.

©2026 Obagi Cosmeceuticals LLC. All rights reserved.
Saypha® MagIQ™ is a prescription injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.

Do not use if you have had previous allergic reactions to hyaluronic acid based ﬁllers, have severe allergies that required in-hospital treatment, are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, are prone to bleeding, or have a bleeding disorder. Do not use while pregnant or breastfeeding, the safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you are planning other cosmetic treatments (such as lasers and chemical peels) as there is a possible risk of inﬂammation at the injection site.

The most common side effects include swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete.

Delayed-onset inﬂammation near the site of dermal ﬁller injections is one of the known adverse events associated with dermal ﬁllers, and cases have been reported to occur at the dermal ﬁller treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inﬂammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed-onset infections, recurrence of herpetic eruptions, superﬁcial necrosis, and scarring at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent, including vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.

Saypha MagIQ is only available through a licensed practitioner. To learn more about serious but rare side effects and Complete Instructions for Use are available at https://www.obagi.com/saypha

To report suspected adverse reactions, contact Obagi Cosmeceuticals LLC at 1-800-636-7546.

REFERENCES:
1. Data on file. Croma-Pharma GmbH; 2025.
2. Puljic A, Frank K, Cohen J, Otto K, Mayr J, Hugh-Bloch A, Kuroki-Hasenöhrl, D. A Scientific Framework for Comparing Hyaluronic Acid Filler Crosslinking Technologies. Gels. 2025; 11(7):487.
3. Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36(5uppl 3):18591865.
4.Downie J, Gold M, Joseph J, Green J, Fabi S, Bank D, Cohen JL, Shamban A. Weiss R, Krames-Juerss A. Monheit G. Multicenter, Randomized Split-Face Trial of a Crosslinked Hyaluronic Acid Filler With Lidocaine for Nasolabial Fold Correction. Aesthet Surg J. 2025 Aug l:sjafl37.
5. Croma-Pharma GmbH. Quatroject: Piston and backstop. Winner of the iF DESIGN AWARD 2024. iF Design. Available at: https://ifdesign.com/en/winner-ranking/project/quatroject/203634
6. Saypha MaglQ. Directions for Use. Croma-Pharma GmbH; 2025.
7. Data on file. FILIDO Clinical Study Report. Croma-Pharma GmbH; 2025.

Afterpay is a service provided by Afterpay US, Inc. and Afterpay US Services, LLC. The service is available to customers in the United States only. Customers will be required to open an Afterpay account and must meet the qualification criteria established by Afterpay. Only purchases having an aggregate value of $100 or more are eligible. Learn More »

For all promotions, we reserve the right to cancel any order due to unauthorized, altered, or ineligible use of offer and to modify or cancel this promotion due to system error or unforeseen problems. Please be advised that certain products have limited distribution and may not be available in your area. Please contact your Obagi skin care physician for more information.

All products/brand names, whether designated by notice or not (©/™), are trademarks of Obagi Cosmeceuticals LLC, and/or its affiliates.

©2025 Obagi Cosmeceuticals LLC. All rights reserved.

Obagi Cosmeceuticals LLC, 3760 Kilroy Airport Way #500, Long Beach, CA 90806

This email was sent to: obagi@mailspo.com

This email was sent by: Obagi Cosmeceuticals LLC

3760 Kilroy Airport Way #500, Long Beach, CA 90806

Manage Preferences | Unsubscribe

Saypha® MagIQ™ is a prescription injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21. Saypha® ChIQ™ is a prescription injectable dermal filler indicated for cheek augmentation and restoring midface volume deficits in adults over the age of 21, administered by subcutaneous and/or supraperiosteal injection.

Do not use Saypha MagIQ or Saypha ChIQ if you have had previous allergic reactions to hyaluronic acid based fillers, have severe allergies that required in-hospital treatment or a history of anaphylaxis, are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, are prone to bleeding, or have a bleeding disorder. Do not use while pregnant or breastfeeding; the safety of use while pregnant or breastfeeding has not been studied.

Tell your doctor if you are planning other cosmetic treatments (such as lasers and chemical peels) as there is a possible risk of inflammation at the injection site. Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, or other substances known to increase coagulation time, as these medications may increase the risk of bruising or bleeding at the gel injection site. Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete.

The most common side effects include swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. For Saypha ChIQ, commonly reported side effects also include firmness, lumps/bumps, discoloration, and tenderness to touch.

Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed-onset infections, recurrence of herpetic eruptions, superficial necrosis, and scarring at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent, including vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.

Saypha MagIQ and Saypha ChIQ are only available through a licensed practitioner. Complete Instructions for Use are available at https://www.obagi.com/saypha.

To report suspected adverse reactions, contact Obagi Cosmeceuticals LLC at 1-800-636-7546.

This email was sent to: obagi@mailspo.com

This email was sent by: Obagi Cosmeceuticals LLC

3760 Kilroy Airport Way #500, Long Beach, CA 90806

Manage Preferences | Unsubscribe

2a:T2cdf,[PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm) [PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm) [RESTORE VOLUME. SUPPORT FIRMNESS. REDEFINE CONTOURS. FIRM. SHOP NOW](https://www.obagi.com/products/elastiderm-facial-moisturizing-serum) [SMOOTH. SHOP NOW](https://www.obagi.com/products/elastiderm-eye-cream-fine-lines-wrinkles) [LIFT. SHOP NOW](https://www.obagi.com/products/lift-up-sculpt-facial-moisturizer) [Targeted Protocols. Precise Outcomes. Skincare meets Injectables](https://www.obagi.com/pages/physician-finder) [PROTECT YOUR INVESTMENT. SHOP NOW.](https://www.obagi.com/products/mineral-uv-barrier-protect-broad-spectrum-spf-40) [shop now](https://www.obagi.com/collections/shop-all) [SHOP AGING & SAGGING](https://www.obagi.com/collections/aging-sagging) [SHOP SKIN DISCOLORATION](https://www.obagi.com/collections/skin-discoloration) [SHOP ACNE & BLEMISH](https://www.obagi.com/collections/acne-blemish) [SHOP SENSITIVE SKIN](https://www.obagi.com/collections/sensitive-skin) [Custom](https://www.instagram.com/obagimedical/) [Custom](https://www.facebook.com/Obagi/) [Custom](https://www.tiktok.com/@obagi) [Custom](https://www.youtube.com/channel/UCAXQSfPXCHMSh-BSkguh3kw) [Custom](https://www.pinterest.com/obagi/) [Custom](https://www.instagram.com/obagimedical/) [Custom](https://www.facebook.com/Obagi/) [Custom](https://www.tiktok.com/@obagi) [Custom](https://www.youtube.com/channel/UCAXQSfPXCHMSh-BSkguh3kw) [Custom](https://www.pinterest.com/obagi/) saypha® is a registered trademark of Croma-Pharma GmbH used under license. All other products/brand names, whether designated by notice or not (©/™), are trademarks of Obagi Cosmeceuticals LLC, and/or its affiliates. ©2026 Obagi Cosmeceuticals LLC. All rights reserved. Saypha® MagIQ™ is a prescription injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.Do not use if you have had previous allergic reactions to hyaluronic acid based ﬁllers, have severe allergies that required in-hospital treatment, are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, are prone to bleeding, or have a bleeding disorder. Do not use while pregnant or breastfeeding, the safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you are planning other cosmetic treatments (such as lasers and chemical peels) as there is a possible risk of inﬂammation at the injection site. The most common side effects include swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete. Delayed-onset inﬂammation near the site of dermal ﬁller injections is one of the known adverse events associated with dermal ﬁllers, and cases have been reported to occur at the dermal ﬁller treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inﬂammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed-onset infections, recurrence of herpetic eruptions, superﬁcial necrosis, and scarring at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent, including vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection. Saypha MagIQ is only available through a licensed practitioner. To learn more about serious but rare side effects and Complete Instructions for Use are available at https://www.obagi.com/saypha To report suspected adverse reactions, contact Obagi Cosmeceuticals LLC at 1-800-636-7546. REFERENCES: 1. Data on file. Croma-Pharma GmbH; 2025. 2. Puljic A, Frank K, Cohen J, Otto K, Mayr J, Hugh-Bloch A, Kuroki-Hasenöhrl, D. A Scientific Framework for Comparing Hyaluronic Acid Filler Crosslinking Technologies. Gels. 2025; 11(7):487. 3. Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36(5uppl 3):18591865. 4.Downie J, Gold M, Joseph J, Green J, Fabi S, Bank D, Cohen JL, Shamban A. Weiss R, Krames-Juerss A. Monheit G. Multicenter, Randomized Split-Face Trial of a Crosslinked Hyaluronic Acid Filler With Lidocaine for Nasolabial Fold Correction. Aesthet Surg J. 2025 Aug l:sjafl37. 5. Croma-Pharma GmbH. Quatroject: Piston and backstop. Winner of the iF DESIGN AWARD 2024. iF Design. Available at: https://ifdesign.com/en/winner-ranking/project/quatroject/203634 6. Saypha MaglQ. Directions for Use. Croma-Pharma GmbH; 2025. 7. Data on file. FILIDO Clinical Study Report. Croma-Pharma GmbH; 2025. Afterpay is a service provided by Afterpay US, Inc. and Afterpay US Services, LLC. The service is available to customers in the United States only. Customers will be required to open an Afterpay account and must meet the qualification criteria established by Afterpay. Only purchases having an aggregate value of $100 or more are eligible. Learn More » For all promotions, we reserve the right to cancel any order due to unauthorized, altered, or ineligible use of offer and to modify or cancel this promotion due to system error or unforeseen problems. Please be advised that certain products have limited distribution and may not be available in your area. Please contact your Obagi skin care physician for more information. All products/brand names, whether designated by notice or not (©/™), are trademarks of Obagi Cosmeceuticals LLC, and/or its affiliates. ©2025 Obagi Cosmeceuticals LLC. All rights reserved. Obagi Cosmeceuticals LLC, 3760 Kilroy Airport Way #500, Long Beach, CA 90806 This email was sent to: obagi@mailspo.com This email was sent by: Obagi Cosmeceuticals LLC3760 Kilroy Airport Way #500, Long Beach, CA 90806 [Manage Preferences](https://manage.kmail-lists.com/subscriptions/update?a=SJacsh&c=01KZHPE7QNDHG8652W3PEE2BER&k=63cf6287a7abedc2fba7a5999e21feab&se=obagi%40mailspo.com&m=01M3YTS6DSXFB8E17J1FFRBCRK&r=01M40VZMYG3QQFK1Y09T60PV6A) | [Unsubscribe](https://manage.kmail-lists.com/subscriptions/unsubscribe?a=SJacsh&c=01KZHPE7QNDHG8652W3PEE2BER&k=63cf6287a7abedc2fba7a5999e21feab&se=obagi%40mailspo.com&m=01M3YTS6DSXFB8E17J1FFRBCRK&r=01M40VZMYG3QQFK1Y09T60PV6A) Saypha® MagIQ™ is a prescription injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21. Saypha® ChIQ™ is a prescription injectable dermal filler indicated for cheek augmentation and restoring midface volume deficits in adults over the age of 21, administered by subcutaneous and/or supraperiosteal injection.Do not use Saypha MagIQ or Saypha ChIQ if you have had previous allergic reactions to hyaluronic acid based fillers, have severe allergies that required in-hospital treatment or a history of anaphylaxis, are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, are prone to bleeding, or have a bleeding disorder. Do not use while pregnant or breastfeeding; the safety of use while pregnant or breastfeeding has not been studied.Tell your doctor if you are planning other cosmetic treatments (such as lasers and chemical peels) as there is a possible risk of inflammation at the injection site. Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, or other substances known to increase coagulation time, as these medications may increase the risk of bruising or bleeding at the gel injection site. Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete.The most common side effects include swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. For Saypha ChIQ, commonly reported side effects also include firmness, lumps/bumps, discoloration, and tenderness to touch.Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed-onset infections, recurrence of herpetic eruptions, superficial necrosis, and scarring at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent, including vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.Saypha MagIQ and Saypha ChIQ are only available through a licensed practitioner. Complete Instructions for Use are available at https://www.obagi.com/saypha.To report suspected adverse reactions, contact Obagi Cosmeceuticals LLC at 1-800-636-7546.Afterpay is a service provided by Afterpay US, Inc. and Afterpay US Services, LLC. The service is available to customers in the United States only. Customers will be required to open an Afterpay account and must meet the qualification criteria established by Afterpay. Only purchases having an aggregate value of $100 or more are eligible. [Learn More »](https://www.afterpay.com/en-US/terms-of-service) For all promotions, we reserve the right to cancel any order due to unauthorized, altered, or ineligible use of offer and to modify or cancel this promotion due to system error or unforeseen problems. Please be advised that certain products have limited distribution and may not be available in your area. Please contact your Obagi skin care physician for more information. All products/brand names, whether designated by notice or not (©/™), are trademarks of Obagi Cosmeceuticals LLC, and/or its affiliates. ©2026 Obagi Cosmeceuticals LLC. All rights reserved. This email was sent to: obagi@mailspo.com This email was sent by: Obagi Cosmeceuticals LLC3760 Kilroy Airport Way #500, Long Beach, CA 90806 [Manage Preferences](https://manage.kmail-lists.com/subscriptions/update?a=SJacsh&c=01KZHPE7QNDHG8652W3PEE2BER&k=63cf6287a7abedc2fba7a5999e21feab&se=obagi%40mailspo.com&m=01M3YTS6DSXFB8E17J1FFRBCRK&r=01M40VZMYG3QQFK1Y09T60PV6A) | [Unsubscribe](https://manage.kmail-lists.com/subscriptions/unsubscribe?a=SJacsh&c=01KZHPE7QNDHG8652W3PEE2BER&k=63cf6287a7abedc2fba7a5999e21feab&se=obagi%40mailspo.com&m=01M3YTS6DSXFB8E17J1FFRBCRK&r=01M40VZMYG3QQFK1Y09T60PV6A) 1f:["$","article",null,{"className":"min-w-0 flex-1 overflow-hidden","aria-label":"Skincare Meets In-Office Filler","children":[["$","$L27",null,{"emailId":"8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd"}],["$","$L28",null,{"email":{"id":"8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd","subject":"Skincare Meets In-Office Filler","previewText":"[PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm)\n\n[PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm)\n\n[RESTORE VOLUME. SUPPORT FIRMNESS. REDEFINE CONTOURS. FIRM. SHOP NOW](ht","sentAt":"2026-10-03T12:47:05.000Z","classification":"marketing","imageCount":18,"thumbnailUrl":"https://mailspo-ingest.imraan-243.workers.dev/img/renders/8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd.jpg","emailType":"newsletter","typeConfidence":"guess","typeBasis":"no stronger signal","brand":"$25:props:brands:752","bodyHtml":"$29","textBody":"$2a","bodyFallback":null}}]]}] a:null f:[["$","title","0",{"children":"Skincare Meets In-Office Filler by Obagi | Mailspo"}],["$","meta","1",{"name":"description","content":"[PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm)\n\n[PROVEN SKINCARE SCIENCE MEETS THE POWER OF IN"}],["$","meta","2",{"name":"robots","content":"index, follow"}],["$","link","3",{"rel":"canonical","href":"https://mailspo.com/emails/8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd"}],["$","meta","4",{"property":"og:title","content":"Skincare Meets In-Office Filler by Obagi | Mailspo"}],["$","meta","5",{"property":"og:description","content":"[PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm)\n\n[PROVEN SKINCARE SCIENCE MEETS THE POWER OF IN"}],["$","meta","6",{"property":"og:url","content":"https://mailspo.com/emails/8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd"}],["$","meta","7",{"property":"og:site_name","content":"Mailspo"}],["$","meta","8",{"property":"og:image","content":"https://mailspo-ingest.imraan-243.workers.dev/img/renders/8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd.jpg"}],["$","meta","9",{"property":"og:image:alt","content":"Obagi email creative: Skincare Meets In-Office Filler"}],["$","meta","10",{"property":"og:type","content":"article"}],["$","meta","11",{"property":"article:published_time","content":"2026-10-03T12:47:05.000Z"}],["$","meta","12",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","13",{"name":"twitter:title","content":"Skincare Meets In-Office Filler by Obagi | Mailspo"}],["$","meta","14",{"name":"twitter:description","content":"[PROVEN SKINCARE SCIENCE MEETS THE POWER OF INJECTABLES. SHOP NOW](https://www.obagi.com/collections/elastiderm)\n\n[PROVEN SKINCARE SCIENCE MEETS THE POWER OF IN"}],["$","meta","15",{"name":"twitter:image","content":"https://mailspo-ingest.imraan-243.workers.dev/img/renders/8fcc5b76-cb2a-4f47-ad4c-cb7a125dbccd.jpg"}],["$","meta","16",{"name":"twitter:image:alt","content":"Obagi email creative: Skincare Meets In-Office Filler"}],["$","link","17",{"rel":"icon","href":"/favicon.ico?favicon.3lxqohtg4uvbd.ico","sizes":"48x48","type":"image/x-icon"}],["$","$L2b","18",{}]]

Search Mailspo